Respiratory Pharms Flashcards

1
Q

• Butorphanol

A
  • Given per os (higher dose; why?) or parenterally
  • Added analgesic benefit but can cause sedation
  • Minimal CVS/respiratory suppression
  • More potent than codeine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

• Codeine

A
  • Use human pediatric formulations
  • Oral absorption is inconsistent in veterinary species
  • Less CNS suppression and constipation than morphine
  • Antitussive effects at sub-analgesic doses more potent than morphine
  • Often used in combination with other respiratory agents
    E.g. antihistamines (chlorampheniramine), expectorants (GGE), decongestants (phenylephrine) and bronchodilators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

• Dextromethorphan

A

o Not a true opiate, similar potency to codeine but less opioid side effects
o In many over-the-counter cold and cough medicines
o Human drug; extra label use and be careful of formulation (usually combined with other drugs e.g., pseudoephedrine which causes excitement)
o Short effect in dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

• Dextromethorphan

A

o Not a true opiate, similar potency to codeine but less opioid side effects
o In many over-the-counter cold and cough medicines
o Human drug; extra label use and be careful of formulation (usually combined with other drugs e.g., pseudoephedrine which causes excitement)
o Short effect in dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

• Antihistamines

A

Can reduce coughing by central effect that alters mucus secretion in the respiratory tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Expectorants

A

• Act by increasing pulmonary mucous secretions BUT decreasing the viscosity thereof
o Act directly or by reflex action* on the tubulo-acinar mucous cells in the bronchi
o Assist with removal of excessive exudates and secretions in the upper respiratory tract
o Moderately beneficial adjunctive respiratory treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mucolytics

A
  • Used to loosen viscid or inspissated pulmonary secretions and help “expectoration”
  • Do not increase volume of secretion like expectorants but help to remove mucous plugs from smaller airways
  • Rehydration of the patient is also important; “steaming” for short periods works well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bromhexine (Bisolvon®)

A
  • Interferes with the production of acid mucopolysaccharide fibres by the goblet cells in the nasal and bronchial mucosa
  • Very effective and antitussive properties at higher doses
  • Can be used for longer periods than Na-acetylcysteine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Na-acetylcysteine/carbocysteine (Mucomyst®)

A
  • Break disulphide bonds and change mucous ion characteristics = altered mucous composition
  • Can be given orally or nebulized
  • SEs: coughing, bronchospasm, ciliary depression
  • Note: Acetylcysteine is also used for treating paracetamol toxicity in cats! Expensive. SEs include hypersensitivity and bronchospasm.
  • Bromhexine is cheaper, safer and good for long term treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bronchoconstriction

A

•Tightening of smooth muscle in the lower airway
•Causes coughing, wheezing and dyspnea
•Can be due to:
- The release of histamine (local or systemic release)
- Cholinergic stimulation (also increased mucous secretion)
- Respiratory mononuclear phagocyte system inflammation releasing histamine, serotonin, prostaglandins etc.
o Particularly NB in cats
o Mononuclear phagocytic system is first line defense in the lungs. Involves monocytes, macrophages and dendritic cells
•Production of reactive oxidative species
o Pollutant particles are linked to development of respiratory track inflammation and asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sympathomimetics

A

•ß2-agonists stimulate a GPCR-2cnd messaging system
o Activate cAMP production
o Ca2+ is bound to the cell membrane and ER
o Not available to cause muscle contraction
o Down-regulate mast cell autacoid release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Adrenaline, isoproterenol

A

• i/v → emergencies
- Reduce histamine release
- Increased activity of the ciliary epithelium of the bronchial mucosa.
• Side effects: tachycardia (β1 receptors) and tremors. May effect blood pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Terbutaline, albuterol, salbutamol

A

• Used in an inhalant → long term use for asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clenbutarol

A
  • For COPD in horses

* Beware late pregnant horses (tocolytic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Parasympatholytic/cholinergic blocking agents

A

•Atropine, glycopyrrolate, ipratropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methylxanthines (theophylline, aminophylline)

A
  • Inhibit phosphodiesterase, reduce breakdown of cAMP.
  • Blocks breakdown of cyclic AMP to 5’ AMP.
  • The increase in cyclic AMP causes bronchodilatation.
  • Side effects: nausea and vomition, diuresis (adenosine receptor antagonism) and hypotension
  • Admin: Slow i/v in emergencies OR orally for maintenance
16
Q

Disodium cromoglycate (mast cell stabiliser)

A
  • Inhibits release of histamine and other autacoids
  • These may cause bronchoconstriction
  • Used for specific types of COPD (prophylactic)
  • Expensive
17
Q

Diphenhydramine and chlorpheniramine

A
  • Usually administered by nebulization

* These are H1 blockers used to prevent histamine binding to mast cells.

18
Q

Corticosteroids

A

• DoC for decreasing inflammatory pulmonary disease such as asthma
• Indirect bronchodilators; decrease autacoid release
• Very effective for allergic bronchoconstrictive disease e.g., feline asthma
o Fluticasone and beclomethasone often used in inhalers
o Can also use prednisolone and dexamethasone systemically.
o Inhalation or topical use reduces systemic side effects
o Can be combined with β2 specific agonists

19
Q

Nasal (and eye) decongestants

A

•Not commonly used because of rebound effects; makes nasal discharge worse than before (occurs 3 – 5 days after treatment).
•Sympathomimetic / α1 agonists,
o Mostly used topically into nasal passages to decrease oedema and secretions for easier breathing
• Phenylephrine, naphazoline.
• Other SE: hypertension, tachycardia or reflex bradycardias, irritability, insomnia.

20
Q

Nebulization

A
  • Administration of drugs dissolved in tiny (ultrasound-formed) droplets
  • Administered via a mask or closed chamber
  • Saline is usually the “vehicle” or sometimes the only ingredient
  • Required frequency is 3 to 4 times a day for 30 – 45 min at a time
  • Droplets are small enough to reach smallest airways (0,5 - 3μm ideal size).
21
Q

Drugs that can be added with nebulization:

A
  • Antibiotics – gentamicin
  • Corticosteroids – beclomethasone
  • Mucolytics – Na-acetylcysteine
  • Bronchodilators – terbutaline
  • Detergents – allevaire
  • Proteolytic enzymes – deoxyribonuclease
  • Proteolytic enzymes break down secretion viscosity, like mucolytics.
  • Detergents also decrease the surface tension and thus the viscosity of secretions.
22
Q

Nebulisation considerations

A
  • Check that drugs are compatible with fluid vehicle and with each other
  • Note that saline alone produces good expectoration effect
  • Nebulization of antibiotics is effective in producing effective drug concentration in respiratory tract but is time consuming, expensive and offers no advantage over systemic administration
  • Some agents can be irritating (mucolytics)
  • Don’t overhydrate; respiratory embarrassment can occur
  • Water particles on deposited on the mucosa of small airways; if rate of deposition exceeds epithelial absorption ability, then will cause increased resistance and blockage of small airway
  • Do not overheat small (< 4kg) and febrile animals as they cannot cool themselves at high humidity
  • Ensure that the components of the nebulization fluid are compatible when preparing a mixture.
  • In many instances drugs are not added to the nebulizing fluid. Nebulization is then mainly used to deposit fluid in the trachea-pulmonary tree to achieve expectoration.
  • Respiratory embarrassment = pulmonary oedema secondary to overhydration.
23
Q

Doxapram

A

• Used for reversal of barbiturates and inhalation anesthetics
- CNS stimulant
• Caesarian-born puppies

24
Q

Antidotes:

A
  • In the case of narcotic overdose e.g., naltrexone

* In the case of α2 agonistic sedation reversal e.g., yohimbine for xylazine

25
Q

In production animals?

A
  • Vaccinate against the infectious agents mostly involved in respiratory pathology
  • Sound management practices
  • Environmental control
  • Of particular importance in feedlot animals
26
Q

Ipratropium bromide

A
  • Anti cholinergic bronchodilator
  • Used for asthma and chronic obstructive pulmonary disease.
  • Does not cause tachycardia, tremors or significantly affect mucus production
  • Not commonly used in vet medicine
27
Q

Atropine

A
  • Anti-muscarinics
  • Cause bronchodilatation but cause undesirable increases in the viscosity of bronchial mucous and reduced ciliary activity.
  • Given in hospital setting/ GA /anaesthesia due to its side effects.